Century Therapeutics (IPSC) Non-Current Deferred Tax Liability (2022 - 2026)
Century Therapeutics (IPSC) posted quarterly Non-Current Deferred Tax Liability of $4.3 million for Q1 2026, down 1.67% year-over-year from $4.4 million in Q1 2025, and little changed quarter-over-quarter from $4.3 million in Q4 2025.
Century Therapeutics (IPSC) Non-Current Deferred Tax Liability (2022 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Non-Current Deferred Tax Liability for 4 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 1.67% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 1.67% YoY), while the FY2025 annual figure was $4.3 million, down 1.67% from the prior year.
- Non-Current Deferred Tax Liability held at $4.3 million in Q1 2026 per IPSC's latest filing, from $4.3 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $4.4 million in Q4 2024 and bottomed at $5000.0 in Q4 2022.
- Historically, Non-Current Deferred Tax Liability has averaged $3.7 million across 4 years, with a median of $4.3 million in 2025.
- On a YoY basis, Non-Current Deferred Tax Liability climbed as much as 29.95% in 2025 and fell as far as 1.67% in 2025.
- Century Therapeutics' Non-Current Deferred Tax Liability stood at $5000.0 in 2022, then surged by 87380.0% to $4.4 million in 2024, then decreased by 1.67% to $4.3 million in 2025, then changed by 0.0% to $4.3 million in 2026.
- Business Quant data shows IPSC's Non-Current Deferred Tax Liability at $4.3 million in Q1 2026, $4.3 million in Q4 2025, and $4.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.30 Mn |
| Jun 30, 2026 | 4.30 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Dec 31, 2025 | 4.30 Mn |
| Sep 30, 2025 | 4.37 Mn |
| Sep 30, 2025 | 4.37 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 4.37 Mn |
| Mar 31, 2025 | 4.37 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Dec 31, 2024 | 4.37 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Jun 30, 2024 | 3.37 Mn |
| Dec 31, 2022 | 5,000.00 |
| Dec 31, 2022 | 5,000.00 |